Lu-177-XT033
177Lu-XT033 is a PSMA targeting radiotherapeutic developed for the treatment [...]
Lu-177-LNC1010
177Lu-LNC1010 is a new radiolabeled drug targeting somatostatin receptors (sstr), [...]
Lu-177-LNC1004
177Lu-LNC1004 is a new radiolabeled drug targeting fibroblast activation protein [...]
Lu-177-ITM-31
177Lu-ITM-31 (177Lu-LuCaFab) is a carbonic anhydrase XII-specific antibody Fab fragment. [...]
Lu-177-DPI-4452
177Lu-DPI-4452 is a 177Lu labeled peptide developed for the treatment [...]
Lu-177-DOTA-EB-FAPi
177Lu-DOTA-EB-FAPi is a new therapeutic agent from the FAPi family. [...]
At-211-NaAt
211At-NaAt (211At-Sodium Astatide) is the Astatine labeled analogue of the [...]
Lu-177-AMTG
177Lu-AMTG is a radiolabeled bombesin analogue developed at the Technical [...]
Y-90-Carbon Microspheres
90Y-Carbon microspheres are a new form of microspheres based on [...]
Y-90-Basixilimab
90Y-Basiliximab is a chimeric, mouse-human monoclonal antibody directed against the [...]